Back

Thrombelastography identifies patients at risk for major adverse cardiovascular events after transcatheter aortic valve implantation

29 August 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Coexistence of coronary disease and aortic stenosis: challenges in percutaneous vs. surgical approach Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor David Hesselbarth

University Heart Center Freiburg-Bad Krozingen, Freiburg (Germany)

3 More presentations in this session

Presentation thumbnail
The increase in non-coronary cusp calcification is associated with the risk of coronary artery occlusion during future transcatheter aortic valve in valve procedures
Doctor K. Onishi (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Assessment of commissural and coronary ostial alignment of aortic valve bioprosthesis after transcatheter aortic valve implantation
Doctor H. Gamal (Cairo, EG)
Abstract Slides Video
Presentation thumbnail
Comparative outcomes of transcatheter aortic valve replacement versus surgical aortic valve replacement in severe aortic stenosis: a systematic review and meta-analysis
Doctor C. Ranasinghe (Birmingham, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Coexistence of coronary disease and aortic stenosis: challenges in percutaneous vs. surgical approach

The Event

Event poster

ESC Congress 2025

29 August 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Increased clot strength following transcatheter aortic valve replacement
thumbnail
Congress Presentation
Hypercoagulability and inflammation indicate increased risk for hypoattenuated leaflet thickening in patients with transcatheter aortic valve replacement
thumbnail
Congress Session
Predictors of TAVI outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources